 |
|
NEWS ALERTS
Receive information about investment opportunities, breaking financial news, company profiles, analysis and more.
Click here to subscribe
|


 |
Free Sign-Up.
No Credit Card Required. |
Small and micro cap stocks poised for big moves. Receive trading alerts, market calls, breaking news and what it means to investors. |
Enter your email address:
*Note: Please reply to the confirmation email you will receive in your inbox.
|
|
|
 |
 |
 |
 |
|
| MIV+THERAPEUTICS+(OBB+:+MIVT) |
| PRESS RELEASES: MIV+THERAPEUTICS+(OBB+:+MIVT) | | JACC Intervention Publishes MIV'S VESTASYNC I Trial Preliminary Results Oct 21, 2008 8:01:43 AM
MIV Therapeutics' CEO Mark Landy Joins Distinguished Leaders Selected to This Year's PharmaVOICE 100 Jul 29, 2008 1:06:01 PM
MIV Announces Effectiveness of 1-for-10 Reverse Stock Split Jun 30, 2008 8:00:16 AM
MIV Board Approves One-for-10 Reverse Stock Split Jun 16, 2008 8:00:14 AM
MIV Therapeutics Featured in Scientific American Online Jun 6, 2008 8:45:16 AM
| First Patients Enrolled in MIV Therapeutics VESTASYNC II Study May 21, 2008 7:30:02 AM
MIV's Stents Subject of Two Live Cases and Several Presentations at EuroPCR May 20, 2008 7:00:12 AM
MIV Therapeutics Featured in Cardiovascular Business News May 6, 2008 8:00:46 AM
MIV'S VESTAsync(TM) Polymer-Free Drug-Eluting Stent to Be Highlighted at Several Presentations at EuroPCR May 5, 2008 9:14:31 AM
MIV Therapeutics' First In-Man Study Data 'Very Encouraging', According To SISM Research Morning Note Apr 10, 2008 8:41:01 AM
|
|
|
 |
|
|
|
|
|
|
|